StonvexLoading…
StonvexStonvexStonvexCore line items from SMRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $152.33M | $174.88M | $236.84M | $167.82M |
Operating Income | $-63.98M | $-41.77M | $-43.16M | $-104.25M |
Net Income | $-60.56M | $-33.64M | $-34.59M | $-96.32M |
EPS (Diluted) | $-0.32 | $-0.17 | $-0.17 | $-0.49 |
Total Assets | $320.93M | $420.18M | $509.76M | $560.85M |
Total Liabilities | $88.79M | $130.74M | $167.31M | $196.65M |
Cash & Equivalents | $104.55M | $142.48M | $215.21M | $210.41M |
Free Cash Flow OCF − CapEx | $-25.13M | $-34.68M | $5.83M | $-78.95M |
Shares Outstanding | 189.68M | 192.05M | 203.33M | 198.53M |